Trial site
Sarah Cannon Cancer Center
- 8running trials
- 9closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Childhood cancers3 trials
- Colorectal cancer3 trials
- Head and neck cancer3 trials
- Melanoma3 trials
- Multiple myeloma3 trials
- Glioblastoma2 trials
- Metastatic breast cancer2 trials
- Ovarian cancer2 trials
- Pancreatic cancer2 trials
- Sarcoma2 trials
- Thyroid cancer2 trials
- and 8 more
- Phase
- Phase 27 trials
- Phase 14 trials
- Phase 1/23 trials
- Phase 33 trials
- Status
- Completed8 trials
- Active, not recruiting7 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- City of Hope Medical Center2 trials
- Ascentage Pharma Group Inc.1 trial
- Bayer1 trial
- BeiGene1 trial
- and 7 more
Running trials
Recruiting
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Active, not recruiting
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Active, not recruiting
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Active, not recruiting
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma
Active, not recruiting
Active, not recruiting
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026